Resultados de búsqueda - Jun‐Hui Sun

  • Mostrando 1 - 11 Resultados de 11
Limitar resultados
  1. 1
    Khdrbs1 drives redifferentiation of bipotential progenitor cell by inhibiting p53 in zebrafish biliary-mediated liver regeneration

    Khdrbs1 drives redifferentiation of bipotential progenitor cell by inhibiting p53 in zebrafish biliary-mediated liver regeneration por Kai Gang, Qi Chen, Jun‐Hui Sun, Tingwei Zhang, Pengcheng Cai, Rui Ni, Jianlong Ma

    Publicado 2025
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  2. 2
    Hypoxia-cleavable and specific targeted nanomedicine delivers epigenetic drugs for enhanced treatment of breast cancer and bone metastasis

    Hypoxia-cleavable and specific targeted nanomedicine delivers epigenetic drugs for enhanced treatment of breast cancer and bone metastasis por Zhaofeng Li, Peixin Liu, Wei Chen, Xueying Liu, Fan Tong, Jun‐Hui Sun, Yang Zhou, Ting Lei, Wenqin Yang, Dong Ma, Huile Gao, Yi Qin

    Publicado 2023
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma

    Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma por Jun‐Hui Sun, Chun‐Hui Nie, Yue‐Lin Zhang, Guan‐Hui Zhou, Jing Ai, Tan‐Yang Zhou, Tong‐Yin Zhu, Aibin Zhang, Weilin Wang, Shusen Zheng

    Publicado 2015
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Development and validation of convolutional neural network-based model to predict the risk of sentinel or non-sentinel lymph node metastasis in patients with breast cancer: a machine learning study

    Development and validation of convolutional neural network-based model to predict the risk of sentinel or non-sentinel lymph node metastasis in patients with breast cancer: a machi... por Mingzhen Chen, Chunli Kong, Guihan Lin, Weiyue Chen, Xinyu Guo, Yaning Chen, Cheng Xue, Minjiang Chen, Changsheng Shi, Min Xu, Jun‐Hui Sun, Chenying Lu, Jiansong Ji

    Publicado 2023
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial

    Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial por Chengxiang Guo, Junlei Zhang, Xin Huang, Yiwen Chen, Jianpeng Sheng, Xing Huang, Jun‐Hui Sun, Wenbo Xiao, Ke Sun, Shunliang Gao, Risheng Que, Yan Shen, Min Zhang, Jian Wu, Xueli Bai, Tingbo Liang

    Publicado 2023
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients

    Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients por Guan‐Hui Zhou, Jun Han, Jun‐Hui Sun, Yuelin Zhang, Tan‐Yang Zhou, Chun‐Hui Nie, Tong‐Yin Zhu, Sheng-Qun Chen, Baoquan Wang, Zi‐Niu Yu, Hongliang Wang, Liming Chen, Weilin Wang, Shusen Zheng

    Publicado 2018
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study

    Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study por Zhi‐Cheng Jin, Bin‐Yan Zhong, Jian-Jia Chen, Hai‐Dong Zhu, Jun‐Hui Sun, Guowen Yin, Naijian Ge, Biao Luo, Wen‐Bin Ding, Wenhui Li, Li Chen, Yu-Qing Wang, Xiaoli Zhu, Yang Weizhu, H. Li, Gao‐Jun Teng

    Publicado 2023
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib

    Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib por Lei Zhang, Wei Xia, Zhiping Yan, Jun‐Hui Sun, Bin‐Yan Zhong, Zhong-Heng Hou, Minjie Yang, Guan‐Hui Zhou, Wansheng Wang, Xingyu Zhao, Junming Jian, Peng Huang, Rui Zhang, Shen Zhang, Jiayi Zhang, Zhi Li, Xiaoli Zhu, Xin Gao, Cai‐Fang Ni

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Irradiation stent with 125I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial

    Irradiation stent with 125I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial por Jian Lü, Jin-He Guo, Jiansong Ji, Yuliang Li, Wei‐Fu Lv, Hai‐Dong Zhu, Jun‐Hui Sun, Weixin Ren, Fujun Zhang, Weidong Wang, Haibo Shao, Guangshao Cao, Hai-Liang Li, Kun Gao, Po Song Yang, Guowen Yin, Guang-Yu Zhu, Fazong Wu, Wujie Wang, Dong Lu, Sheng-Qun Chen, Jie Min, Yang Zhao, Rui Li, Ligong Lu, Wan Yee Lau, Gao‐Jun Teng

    Publicado 2023
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study

    Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter... por Dongdong Xia, Wei Bai, Enxin Wang, Jiaping Li, Xiaoming Chen, Zhexuan Wang, Mingsheng Huang, Ming Huang, Jun‐Hui Sun, Yang Weizhu, Zhengyu Lin, Jianbing Wu, Zixiang Li, Shufa Yang, Xu Zhu, Zaizhong Chen, Yanfang Zhang, Wenzhe Fan, Qicong Mai, Rong Ding, Chun‐Hui Nie, Long Feng, Xueda Li, Wukui Huang, Jun Sun, Qiuhe Wang, Yong Lv, Xiaomei Li, Bohan Luo, Zhenyu Wang, Jie Yuan, Wengang Guo, Kai Li, B. Li, Ruijun Li, Zhanxin Yin, Jielai Xia, Guohong Han

    Publicado 2022
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

    Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001) por Hai‐Dong Zhu, Hai-Liang Li, Mingsheng Huang, Yang Weizhu, Guowen Yin, Bin‐Yan Zhong, Jun‐Hui Sun, Zhi‐Cheng Jin, Jian-Jia Chen, Naijian Ge, Wen‐Bin Ding, Wenhui Li, Jinhua Huang, Wei Mu, Shanzhi Gu, Jiaping Li, Hui Zhao, Wen Shu-wei, Yanming Lei, Yusheng Song, Chunwang Yuan, Weidong Wang, Ming Huang, Wei Zhao, Jianbing Wu, Song Wang, Xu Zhu, Jianjun Han, Weixin Ren, Zaiming Lu, Wenge Xing, Yong Fan, Hailan Lin, Zishu Zhang, Guohui Xu, Wenhao Hu, Qiang Tu, Hongying Su, Chuansheng Zheng, Yong Chen, Xuya Zhao, Zhu-ting Fang, Qi Wang, Jinwei Zhao, Aibing Xu, Jian Xu, Qinghua Wu, Huanzhang Niu, Jian Wang, Feng Dai, Duiping Feng, Qingdong Li, Rong-Shu Shi, Jiarui Li, Guang Yang, Hai‐Bin Shi, Jiansong Ji, Yue Liu, Zheng Cai, Po Song Yang, Yang Zhao, Xiaoli Zhu, Ligong Lu, Gao‐Jun Teng

    Publicado 2023
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: